The decision-making role of the patient in localised prostate cancer treatment

Published on Mar 8, 2017in Australasian Journal of Information Systems
· DOI :10.3127/AJIS.V21I0.1382
Luke L Wang3
Estimated H-index: 3
Weranja Ranasinghe10
Estimated H-index: 10
Our objective was to review the current literature on patient participation and decision-making in the treatment selection process for localised prostate cancer, and to evaluate capacity for improvement. Methods: 42 articles from our literature search were deemed eligible and relevant for review. We reviewed studies on all facets of the treatment decision-making process with most number of articles (16) on treatment preferences. Results: The majority of the patients prefer an active or collaborative role in decision-making. Patients are seeking information from a myriad of sources but the recommendation from their treating physician is often the most influential on the final decision. Radical prostatectomy is more likely to be selected in patients who view a cure for cancer as being of the utmost importance and radiation therapy is preferred in patients who are concerned about treatment side effects. Conclusion: Currently no ideal tool exists to assist patients in making informed treatment decisions that also takes into account patients’ values and preferences. We encourage collaborative partnership in a multidisciplinary setting to optimise this process and individualised risk-based decision-making tools may provide a better pathway to assist patients reach decisions.
📖 Papers frequently viewed together
15 Citations
#1Julia J. van Tol-Geerdink (Radboud University Nijmegen)H-Index: 9
#2Jan Willem H. Leer (Radboud University Nijmegen)H-Index: 43
Last. Peep F. M. Stalmeier (Radboud University Nijmegen)H-Index: 31
view all 8 authors...
Objective To develop and validate new regret scales and examine whether a decision aid affects different aspects of regret in the treatment choice for prostate cancer. Methods This was a multicentre trial (three sites) with imbalanced randomization (1 : 2). From 2008 to 2011, patients with localized prostate cancer were randomized 1 : 2 to usual care (N = 77) or usual care plus a decision aid presenting risks and benefits of different treatments (N = 163). The treatments were surgery and (extern...
30 CitationsSource
#1Prajakta Adsul (SLU: Saint Louis University)H-Index: 6
#2Ricardo J. Wray (SLU: Saint Louis University)H-Index: 17
Last. Sameer Siddiqui (SLU: Saint Louis University)H-Index: 17
view all 6 authors...
Purpose: Despite established evidence for using patient decision aids, use with newly diagnosed patients with prostate cancer remains limited partly due to variability in aid characteristics. We systematically reviewed decision aids for newly diagnosed patients with prostate cancer.Materials and Methods: Published peer reviewed journal articles, unpublished literature on the Internet and the Ottawa decision aids web repository were searched to identify decision aids designed for patients with pr...
35 CitationsSource
#1Philippe D. Violette (McMaster University)H-Index: 15
#2Thomas AgoritsasH-Index: 40
Last. Kari A.O. Tikkinen (UH: University of Helsinki)H-Index: 32
view all 11 authors...
Patients who are diagnosed with localized prostate cancer need to make critical treatment decisions that are sensitive to their values and preferences. The role of decision aids in facilitating these decisions is unknown. The authors conducted a systematic review of randomized trials of decision aids for localized prostate cancer. Teams of 2 reviewers independently identified, selected, and abstracted data from 14 eligible trials (n = 3377 men), of which 10 were conducted in North America. Of th...
85 CitationsSource
#1Jeremy GrummetH-Index: 21
#2Mahesha WeerakoonH-Index: 7
Last. Declan G. MurphyH-Index: 107
view all 8 authors...
Objective To determine the rate of hospital re-admission for sepsis after transperineal (TP) biopsy using both local data and worldwide literature, as there is growing interest in TP biopsy as an alternative to transrectal ultrasonography (TRUS)-guided biopsy for patients undergoing repeat prostate biopsy. Patients and Methods Pooled prospective databases on TP biopsy from multiple centres in Melbourne were queried for rates of re-admission for infection. A literature review of PubMed and Embase...
144 CitationsSource
#1Floyd J. Fowler (University of Massachusetts Boston)H-Index: 68
Last. Michael J. BarryH-Index: 108
view all 3 authors...
Importance Informing and involving patients in their medical decisions is increasingly becoming a standard for good medical care, particularly for primary care physicians. Objective To learn how patients describe the decision-making process for 10 common medical decisions, including 6 that are most often made in primary care. Design A survey of a national sample of adults 40 years or older who in the preceding 2 years had either experienced or discussed with a health care provider 1 or more of 1...
113 CitationsSource
#1Julia J. van Tol-Geerdink (Radboud University Nijmegen)H-Index: 9
#2Jan Willem H. Leer (Radboud University Nijmegen)H-Index: 43
Last. Peep F. M. Stalmeier (Radboud University Nijmegen)H-Index: 31
view all 8 authors...
WHAT'S KNOWN ON THE SUBJECT? AND WHAT DOES THE STUDY ADD?: Many patients are eligible for more than one treatment option for prostate cancer. In usual care, urologists have a large influence on the treatment choice. Decision aids, providing balanced information on the pros and cons of different treatment options, improve the match between patient preferences and treatment received. In men eligible for both surgery and external beam radiotherapy, treatment choice differed by hospital. Across the ...
49 CitationsSource
#1Räto T. StrebelH-Index: 13
#2Tullio Sulser (UZH: University of Zurich)H-Index: 36
Last. Richard CathomasH-Index: 29
view all 10 authors...
Purpose New multimodality treatment approaches for prostate cancer require multidisciplinary management of patients. We aimed to assess the current practices of multidisciplinarity and their possible implications in treatment management in Switzerland.
9 CitationsSource
#1Matthew J. Resnick (Vandy: Vanderbilt University)H-Index: 10
#1Matthew J. Resnick (Vandy: Vanderbilt University)H-Index: 26
Last. David F. Penson (Vandy: Vanderbilt University)H-Index: 80
view all 12 authors...
Background The purpose of this analysis was to compare long-term urinary, bowel, and sexual function after radical prostatectomy or external-beam radiation therapy. Methods The Prostate Cancer Outcomes Study (PCOS) enrolled 3533 men in whom prostate cancer had been diagnosed in 1994 or 1995. The current cohort comprised 1655 men in whom localized prostate cancer had been diagnosed between the ages of 55 and 74 years and who had undergone either surgery (1164 men) or radiotherapy (491 men). Funct...
640 CitationsSource
#1Lixin Song (UNC: University of North Carolina at Chapel Hill)H-Index: 12
#2Ronald C. Chen (UNC: University of North Carolina at Chapel Hill)H-Index: 32
Last. Paul A. GodleyH-Index: 34
view all 11 authors...
BACKGROUND: The current study examined how patients' sociodemographic, cancer-related, and subjective affective factors impacted their role in treatment decision-making. METHODS: The patient sample (N = 788) was taken from a prospective follow-up study of a population-based cohort. Participants included 343 African American and 445 Caucasian-American patients with clinically localized prostate cancer. Multinomial logistic regression was used to investigate relations between the explanatory varia...
31 CitationsSource
#1Nynikka R. Palmer (Wake Forest University)H-Index: 12
#2Janet A. Tooze (Wake Forest University)H-Index: 45
Last. Nancy E. Avis (Wake Forest University)H-Index: 58
view all 5 authors...
Objective To examine African-American prostate cancer (PCa) survivors’ involvement in treatment decision-making (TDM), and examine the association between TDM and quality of life (QOL), using secondary data.
16 CitationsSource
Cited By2
#1Allan Ben Smith (UNSW: University of New South Wales)H-Index: 17
#2Orlando Rincones (UNSW: University of New South Wales)H-Index: 3
Last. Afaf Girgis (UNSW: University of New South Wales)H-Index: 67
view all 9 authors...
Abstract Objective To understand how best to support men diagnosed with localised prostate cancer to decide which treatment option best suits their needs, when robotic prostatectomy and radiotherapy are equally appropriate to offer them. Methods Twenty-five men recently diagnosed with localised prostate cancer completed semi-structured interviews asking about information/decision-making needs before and/or after attending a combined clinic in which they consulted a urologist and a radiation onco...
6 CitationsSource
#1Katya Tentori (University of Trento)H-Index: 15
#2Stefania Pighin (University of Trento)H-Index: 10
Last. Vincenzo Crupi (UNITO: University of Turin)H-Index: 15
view all 4 authors...
BACKGROUND: The management of localized prostate cancer is challenging because of the many therapeutic options available, none of which is generally acknowledged as superior to the others in every respect. The selection of the most appropriate treatment should therefore reflect patients' preferences. OBJECTIVE: The purpose of the following study was to pilot a new approach for investigating whether urologists who had previously provided patients with therapeutic advice actually knew their patien...
2 CitationsSource